Related Experiment Videos
Antibodies in relation to gluten intake
1Institute of Medical Technology, University of Tampere, Tampere, Finland. markku.maki@uta.fi
Digestive Diseases (Basel, Switzerland)
|April 20, 1999
Summary
Serological tests like tissue transglutaminase antibodies aid coeliac disease screening. However, small-bowel biopsy remains the most sensitive method for monitoring gluten-free diet adherence and detecting minor dietary issues.
Area of Science:
- Gastroenterology and Immunology
Background:
- Coeliac disease diagnosis relies on serological screening using tests such as reticulin, endomysial, gliadin, and tissue transglutaminase antibodies.
- While valuable, current serological tests are not perfectly predictive of coeliac disease or dietary adherence.
Purpose of the Study:
- To evaluate the role of various serological antibody tests in screening and monitoring coeliac disease.
- To compare the sensitivity of serological tests with small-bowel mucosal biopsy for assessing the effectiveness of a gluten-free diet.
Main Methods:
- Review of serological antibody tests including reticulin, endomysial, gliadin, and tissue transglutaminase antibodies.
- Assessment of the predictive value of these tests in identifying coeliac disease and monitoring gluten-free diet compliance.
- Comparison of serological monitoring with small-bowel mucosal biopsy.
Main Results:
- Reticulin/endomysial antibodies can predict future coeliac disease in individuals with normal small-bowel morphology.
- Serological tests can indicate inadequate adherence to a gluten-free diet.
- Minor dietary transgressions and subtle mucosal damage may not be detected by serological tests.
Conclusions:
- Serological tests are useful for coeliac disease screening and identifying inadequate gluten-free diets.
- Small-bowel mucosal biopsy remains the gold standard for monitoring gluten-free diet effectiveness due to its superior sensitivity in detecting minor issues.